ein medizinhistorischer Irrtum führte zur Verbannung von anorganischem JOD aus der Medizin. Tatsächlich ist JOD zur Behandlung von Schilddrüsen-Überfunktionen prompt wirksam.
- ausreichende JOD-Versorgung normalisiert Östrogen-Dominanz
- verbessert Herzrhytmus-Störungen – sodass auf das JODHÄLTIGE Amiodaron verzichtet werden kann
- reduziert die Häufigkeit von Magenkrebs, Eierstock-, Prostata- und Brust-Krebs
- reguliert PCO und andere Hormon-assoziierten Probleme
- normalisiert alle Schilddrüsen-Erkrankungen, v.a. die Schilddrüsen-Überfunktion
schlampige Wissenschaft hängt JOD das Label einer toxischen Substanz um
Der vielfach ausgezeichnete Endokrinologe und Gynäkologe Professor Guy E. Abrahams – UCLA School of Medicine – hat in einem 2002 publiziertem Artikel den historischen Sachverhalt um den s.g. Wolff-Charkofsky-Effekt aufgeklärt.
Wolff-Charkofsky: Jod-Überschuss führt zur Schilddrüsen-Unterfunktion (1948)
Tatsächlich ist dieser Wolff-Chaikoff Effekt ein frappierender medizin-historischer Irrtum, wie der Endokrinologe und UCLA Professor Dr. Guy Abrahams 2002 und in vielen anderen Papers zeigen konnte.
Ich empfehle allen Ärzten diesen Artikel zu lesen, zumindestens meine Hervorhebungen
Fettdruck bzw. farbige Markierung im Text = Hervorhebung durch Dr. Retzek
The Wolff-Chaikoff Effect: Crying Wolf?
Shortly after the Axis powers capitulated and World War II came to an end, UC-Berkley dropped a bombshell in 1948, which became known as the Wolff-Chaikoff (W-C) effect.1 Where the swords of many nations failed, the pens of two men succeeded. The W-C effect resulted in the removal of iodine from the food supply, and most likely caused a lot of misery and death in the US due to its negative impact on iodine consumption by the population and on the use of inorganic, non-radioactive iodine in medical practice.2-4
The W-C effect is supposedly the inhibitory effect of peripheral inorganic iodide (PII) levels equal to or greater than 0.2 mg/L (10-6M) on the organification of iodide by the thyroid gland of rats, resulting supposedly in hypothyroidism and goiter. These rats never became hypothyroid and thyroid hormones were not measured in their plasma. Nevertheless, the W-C effect, which did not even occur in the rats, was extrapolated to humans. The correct interpretation of the results obtained in rats from the W-C experiments is: Iodide sufficiency of the thyroid gland was achieved when serum inorganic iodide levels reached 10-6M, as we previously discussed.2-4 These law-abiding rats refused to become hypothyroid and instead followed their normal physiological response to the iodide load. They were unjustly accused of escaping from the W-C effect. Labeling these innocent rats as fugitives from the W-C effect was a great injustice against these rodents.
To the disgrace and stupidity of the medical profession, US physicians swallowed the W-C forgery uncritically, which resulted in a moratorium on the clinical use of inorganic, non-radioactive iodine in effective amounts. However, this moratorium did not include toxic organic iodine-containing drugs and radioiodide. The iodophobic mentality prevented further research on the requirement for inorganic, non-radioactive iodine by the whole human body, which turns out to be 100-400 times the very recently established RDA.2-4 Prior to World War II and the W-C publication, US physicians used Lugol solution safely, effectively and extensively in both hypo- and hyperthyroidism.3 Wolff and Chaikoff acknowledged the excellent and dramatic results achieved consistently with the use of Lugol solution in hyperthyroidism.1 But they postulated erroneously that these results were due to the fictitious W-C effect. In the discussion section of their publication, Wolff and Chaikoff1 stated: „Ever since the introduction of iodine therapy for the treatment of Graves‘ disease by Plummer in 1923,6 the mechanism by which iodine brings about a dramatic remission of signs and symptoms in patients suffering from this disease has attracted considerable attention. We do believe that our findings, even though they deal with normal thyroid tissue, justify the conclusion that an interference in organic binding of iodine by the gland is an integral part of the mechanism by which iodine brings about a remission in Graves‘ disease.“
Wartofsky, et al5 in 1970 evaluated the effect of Lugol solution, administered at five drops (30 mg iodine/iodide) three times a day in five thyrotoxic patients. Following a well-designed protocol, they reported, „It is concluded that the rapid decrease in T4 secretion induced by iodine is not the result of an acute sustained inhibition of T4 synthesis (the Wolff-Chaikoff effect), but rather results from an abrupt decrease in the fractional rate of thyroid T4 release.“ Therefore, in hyperthyroidism, iodine/iodide in Lugol at a daily dose of 90 mg induced a physiological trend toward normalization of thyroid function, a beneficial effect, not the fictitious W-C effect as proposed by Wolff and Chaikoff. It is amazing that the W-C effect, which is still mentioned in iodophobic publications, has never been confirmed in rats by other investigators and has never been demonstrated in any animal species.
In 1948, there was already evidence that the W-C effect, if it was for real in rats (and it was not), did not occur in humans. The Lugol solution and saturated solution of potassium iodide (SSKI) were used extensively in medical practice for patients with asthma. The recommended daily amount was 1,000-2,000 mg.6 This amount was used in patients with asthma, chronic bronchitis, and emphysema for several years. Hypothyroidism and goiter were not common in this group of patients. Those amounts of iodine would have resulted in serum inorganic iodine levels 100 times higher than the serum inorganic iodide levels of 10-6M claimed by Wolff and Chaikoff to result in the W-C effect.3
The most quoted reference for the validation of the W-C effect in humans is not the original 1948 publication, but a review by Wolff in 1969, with the title „Iodide goiter and the pharmacologic effects of excess iodide,“ published in the American Journal of Medicine.7 This article was obviously addressed to clinicians, and coming from the National Institute of Health gave it credibility. Since it was published in a medical journal, physicians assumed that the W-C effect had been demonstrated in human subjects, as insinuated by Wolff in his review.
The expressions „iodide goiter“ and „excess iodide“ were used effectively by clinical endocrinologists in their publications to create the iodophobic mentality now prevalent in the medical community.3 For example, what is considered „excess“ by endocrinologists represents only 3% of the average daily intake of iodide by 60 million mainland Japanese, a population with a very low incidence of cancer overall, and in particular of the female reproductive organs.2 Just think how healthy our population would be if the average consumption of iodine/iodide by supplementation was in the range consumed by mainland Japanese, i.e., in the range recommended by US physicians in the form of Lugol solution before World War II3.
In the first paragraph of the 1969 publication, Dr. Wolff7 stated the purpose of his review: „This review concerns itself with the effects of excess iodide, i.e., amounts greater than those needed for the production of normal amounts of the thyroid hormones – a rough estimate of the daily iodide requirement for man would be about 200 ug of iodine per day.“ So, now, we know that Dr. Wolff defined excess iodide as daily intake above 200 ug and with the implication that the only need for iodide by the human body was for the synthesis of thyroid hormones. This review was published before the RDA for iodine was established in 1980 and confirmed in 1989.4 Dr. Wolff7 arbitrarily defined four degrees of iodide excess.
First Degree Excess: Iodide levels slightly above 200 ug/day qualify for first degree excess. „Positive iodine balances may be prolonged and lead to considerable increases in hormone stores.“ In 1964, five years before Wolff published his review, Koutras, et al8 from Scotland published a well-designed study to look into that possibility. They administered potassium iodide to normal subject for 12 weeks in daily amounts of 100 ug, 200 ug, and 800 ug. There was a proportional increase in iodide uptake by the thyroid gland, but not greater than 6-7 mg iodide over the 12-week period. Peripheral thyroid hormone (PBI) did not change appreciably.
The authors stated: „From our evidence, it appears that, with all the doses used, the thyroid took up about 6-7 mg of iodine before an equilibrium with the new PII (plasma inorganic iodide) was reached.“ Regarding the W-C effect, the authors stated: „There is no evidence that the same mechanism is also responsible for the decreased iodide utilization which accompanies small increases in the PII levels.“ Wolff made no reference to Koutras‘ paper, although it was published in the Journal of Clinical Endocrinology, not an obscure journal.
Second Degree Excess: „A larger amount which can inhibit iodine release from the thyrotoxic human thyroid gland.“ What is wrong with that? Before the introduction of the toxic goitrogens, the thiocarbamide drugs, the Lugol solution was used extensively during the early and mid 1900s in medical practice for the treatment of hyperthyroidism and with good results. With daily intake ranging from 6 mg to 180 mg iodine, a success rate as high as 90% was achieved,3 saving patients‘ thyroids from radioiodide and the toxic goitrogens.
Third Degree Excess: „A slightly greater intake which leads to inhibition of organic iodine formation and which probably causes iodide goiter. This is the so-called Wolff-Chaikoff effect.“ Dr. Wolff seems to contradict himself. „The rarity of iodide goiter in the face of the extensive exposure of a great many patients to iodide has not been satisfactorily explained.“ Without preconceived ideas, it is easily explained — inorganic, non-radioactive iodine is safe. „The demonstration of the Wolff-Chaikoff effect in man remains presumptive.“ The demonstration of the W-C effect in any animal species remains presumptive.
Concerning iodide goiter, Wolff stated: „The most common form of iodide goiter is that seen in Hokkaido.“ The Japanese authors investigating the Hokkaido goiter did not think iodide was the cause of the thyroid enlargement since Japanese subjects from Tokyo without goiter excreted similar levels of iodide in their urine.9,10 Excess goitrogens in the diet of those subjects could explain their normal thyroid function in the presence of goiter, and this problem has since been solved. In 1994, 27 years after the original publication by Suzuki, et al,9 Konno, et al11 stated: „Kelp-induced endemic goiter was reported to occur in the coastal regions of Hokkaido nearly 30 years ago. Such goiter has now disappeared.“ Please note that Konno, et al called it „kelp-induced goiter“ whereas Wolff called it „iodide-goiter,“ without any evidence that iodide was the cause. Wolff blamed iodide for the Hokkaido goiter without any scientific data, and further, he stated that this iodide goiter was probably caused by the W-C effect, a double assumption.
Fourth Degree Excess: „Very high levels of iodide which saturate the active transport of this anion.“ We have previously demonstrated from a review of the literature that saturation occurs at 50 mg iodide per day in human adults2 and thyroid uptake of iodide reached a maximum of 600 ug/day. That level was maintained when higher amounts of iodide were ingested. Essentially, the thyroid iodide transport system will pick up increasing amounts of iodide as peripheral iodide levels increase, but up to a point. When saturation is reached, however, thyroid hormone levels were maintained within normal limits.
Let us recapitulate by defining the W-C effect. When normal rats are injected with a single intraperitoneal dose of potassium iodide mixed with radioiodide tracer, in amounts five times or more greater than the total amounts of iodide measured in the thyroid gland of those rats, the organic binding of radioiodide by the thyroid becomes undetectable as long as serum levels of inorganic iodide are maintained above 19 ug percent (10-6M). As we previously discussed,2 radioiodide uptake by the thyroid gland should be zero when stable (non-radioactive) iodide sufficiency of the thyroid gland is achieved. Therefore, the so-called blockage of organification of radioiodide by the thyroid gland when serum inorganic iodide reached 10-6M is really the amount of serum inorganic iodide needed for thyroid sufficiency.2 There is no blockage of organification of stable iodide by the thyroid gland.
The fictitious W-C effect initiated the iodophobic era, which is still alive and well more than 50 years later. This was the beginning of the end of inorganic, non-radioactive iodine in the form of Lugol solution, used extensively by pre-World War II US physicians for both hypo- and hyperthyroidism.3 What was it about this publication that caused the capitulation of US physicians who exchanged Lugol solution for thyroid hormones in iodine deficiency-induced hypothyroidism and simple goiter and for toxic goitrogens and radioiodide in iodine deficiency-induced hyperthyroidism? The answer is medical iodophobia, the fear of using and recommending inorganic, non-radioactive iodine in amounts previously used safely and effectively in medical practice. What was it in the 1948 Wolff-Chaikoff publication1 and in Wolff’s review7that resulted in medical iodophobia? The answer is that they were iodophobic publications. What is an iodophobic publication? It is a publication that promotes iodophobic misinformation in order to discourage the use of inorganic, non-radioactive iodine in the proper amount.
Medical iodophobia resulted in the thyroid hormone thyroxine replacing iodine in iodine deficiency-induced simple goiter and hypothyroidism. Thyroxine has been the most prescribed drug in the US for several years. So, the manufacturers of thyroxine benefited tremendously from this deception. It also resulted in the destruction of the thyroid gland by means of radioiodide in patients with hyperthyroidism caused by iodine deficiency, although this condition had previously been treated successfully with Lugol solution.3 The radioablation of the thyroid gland with radioiodide resulted in 90% of these patients becoming hypothyroid within the first year and eventually joining the ever-increasing thyroxine-consuming population.3
Supplying thyroid hormones to iodine-deprived individuals masks the iodine deficiency and can result in a zombie-like effect. The patients are capable of performing physical work but are not able to think and reason at maximum capacity. An even greater negative effect is realized if iodine deprivation is combined with goitrogen saturation, using the potent goitrogens bromide, fluoride, and perchlorate in the food and water supply.
Iodine is involved in many vital mental and physical functions, and yet whole body sufficiency for iodine has never been determined. Why? Medical textbooks discuss inorganic, non-radioactive iodine only in relation to the most severe deficiencies of this essential element: cretinism, hypothyroidism, and endemic goiter. Based on an iodine/iodide loading test developed by the author to assess whole body sufficiency for iodine, the amounts of iodine needed for whole body sufficiency and optimal physical and mental health are 250-1,000 times higher than the amount of iodine needed to control cretinism, hypothyroidism, and endemic goiter.3-4
The use of optimal amounts of iodine in the prevention of cancer of the female reproductive organs was proposed by Stadel, from the National Institute of Health in 1976, 29 years ago.12 So far, no such study has been published. There seems to be a moratorium on iodine research in effective amounts, thanks to the W-C effect. Dr. B. Eskin has attempted to reproduce in human subjects his excellent results on iodine and breast cancer observed in female rats.13-15 He proposed clinical studies in human subjects using iodine in amounts based on bodyweight equivalent to those observed to be effective in the rats. He was told this could not be done because of the W-C effect.16
The W-C effect, combined with medical stupidity, has caused enough damage. It is time US physicians and other health care professionals wake up and realize that they have been deceived. They should stop crying Wolff and shake off the W-C effect.
Since our series of publications exposing the damaging effect of medical iodophobia,2-4, 17-20 there is evidence that the anti-iodine side has called to action its damage control team. We have previously documented the relatively high intake of iodine by mainland Japanese with a mean daily intake of 13.8 mg.2 This amount was confirmed by spot urine samples from a large group of mainland Japanese.21 This author calculated that Japanese fetuses are exposed to maternal serum iodide levels of 10-5M to 10-6M, which is the ideal range for optimal function.4 Mainland Japanese are one of the healthiest populations on earth.2 More than 95% of the iodine consumed by mainland Japanese is obtained from seaweed. By removing seaweed from the Japanese diet, their daily intake of iodine would drop 100-fold and would reach the low levels of intake observed in the US.
If iodine gains publicity as the active ingredient in seaweed, protecting mainland Japanese from the degenerative diseases of the Western World, this would be a deathblow to medical iodiophobia. In order to maintain the iodophobic mentality, it is necessary to keep emphasizing the toxicity of iodine in seaweed; and then, divert attention from the fact that iodine is the active ingredient in seaweed that is detrimental to cancers of the female reproductive organs and many of the diseases of Western civilization. In your list of possible bioactive anticarcinogenic substances in seaweed, avoid mentioning iodine at all costs.
This is a form of doublespeak. Seaweed is bad for you because it contains the toxic element iodine; seaweed is good for you because of some unknown factors protecting you against breast cancer, but more research is needed. This kind of confusion works effectively in a population that is already iodine-deprived. It would become totally ineffective if the target population becomes iodine-sufficient because the improved cognition induced by iodine sufficiency would render this deception very transparent.
With the above information as background, let us now examine iodophobic propaganda in action. There are two major ways that this is being done:
- Emphasizing the toxicity of iodine in seaweed, using newborns and children as victims to get the greatest emotional impact.
- Diverting attention from the fact that iodine is the active ingredient in seaweed against the carcinogenic effect of estrogens on female reproductive organs and against many other diseases of the Western World, while pointing to some other factors in seaweed eliciting these beneficial effects.
And to do all this effectively, they make sure the iodophobic publications get wide coverage on the Internet.
Emphasizing the Toxicity of Iodine in Seaweed
Newborns as Victims: In the December 2004 issue of Thyroid, Japanese investigators22 reported that out of 37,724 Japanese infants screened for congenital hypothyroidism, 34 infants had elevated serum TSH levels. Out of the 34 infants, no cause could be found for 15 cases, so the authors decided that in these 15 cases, the cause of elevated TSH was due to „excess iodine“ intake by the mothers during pregnancy. The authors stated: „We detected no other cause of hyperthyrothrophinemia among these 15 infants.“ Did they really look for other causes?
Nishiyama, et al20 did not fail to mention the fictitious W-C effect as the cause of elevated TSH and reduced thyroxine in these 15 infants even though these infants had normal free thyroxine levels and Wolff and Chaikoff never demonstrated elevated TSH and low thyroxine in their rats, or, for that matter, in any animal species: „Because of antithyroid effects of an iodine excess, the so-called Wolff-Chaikoff effect, which blocks the uptake of iodine by the thyroid gland, leads to reduced T4 and increased TSH.“
According to Wolff,7 iodine intake of 2 mg or more is considered „excessive and potentially harmful.“ So, Nishiyama, et al22 divided those 15 infants into two groups: one group with maternal intake of iodine below 2 mg and another group with maternal intake above 2 mg. However, in both groups, the reported intake of iodine by the pregnant women was much lower than the national average intake of iodine.2
Nishiyama, et al22 reported that their so-called control group of pregnant women ingested only 0.25-0.48 mg iodine/day, which is within the range of iodine intake in the US. Women in their control group were asked to abstain from seaweed for a few days. How convenient! In the mothers who supposedly ingested „excessive iodine“ from their diet, the amount of iodine ingested was 5-10 times lower than the national average intake by mainland Japanese.2,3 Normal thyroid hormones and TSH were observed in these women. All 15 infants from these mothers had normal serum free T4 levels. The physical and psychomotor developments of the 15 infants were normal.
After centuries of consuming safely large amounts of iodine from seaweed, why would iodine in seaweed suddenly become toxic to mainland Japanese? The data presented in Nishiyama’s publication do not justify the alarming implication of the title of that publication. The expression „excessive iodine intake“ is taken from Wolff’s review.7 More than 50 years after the Wolff-Chaikoff forgery, it is still quoted in iodophobic publications.
Children as Victims: Shortly after the publication on „excess iodine“ in newborns,22 another publication in the American Journal of Clinical Nutrition23 reported that urine iodide concentrations greater than 0.5 mg/L was associated with increased thyroid volume in multiethnic groups of children between six and 12 years old. Analysis of the data in Table I of that publication revealed only children from Hokkaido, Japan, showed increased thyroid volumes of significance compared to the other groups: 2.16 to 2.59 ml for all the other groups; and 2.86 and 4.91 ml for the 2 groups from Hokkaido. This area of Japan is known to have a high incidence of euthyroid goiter. Suzuki, et al9 first reported this finding in 1965 but did not think that iodine was the cause of this goiter. He commented: „Considering the paucity of reported cases of iodine goiter with the widespread usage of iodine medication, we cannot exclude factors other than excessive intake of dietary iodine as a cause of the goiter.“
Diverting Attention from the Anticarcinogenic Effect of Iodine in Seaweed
Based on an extensive review of breast cancer epidemiological studies, R.A. Wiseman24 came to the following conclusions: 92-96% of breast cancer cases are sporadic; there is a single cause for the majority of cases; the causative agent is deficiency of a micronutrient that is depleted by a high-fat diet; and if such an agent is detected, intervention studies with supplementation should lead to a decline in the incidence of breast cancer. It is the opinion of several investigators that this protective micronutrient is the essential element iodine.2 Demographic surveys of Japan and Iceland revealed that both countries have a relatively high intake of iodine and low incidences of simple endemic goiter and breast cancer. Whereas in Mexico and Thailand, just the reverse is observed — a high incidence of both endemic goiter and breast cancer.25 Thomas, et al26,27 have demonstrated a significant and inverse correlation between iodine intake and the incidence of breast, endometrial, and ovarian cancer in various geographical areas. Thyroid volume, measured by ultrasonometry and expressed as ml, is significantly larger in Irish women with breast cancer than controls with mean values of 12.9 ± 1.2 in controls and 20.4 ± 1.0 in women with breast cancer.28 Intervention studies in female rats by Eskin13-15 are very suggestive of a facilitating role of iodine deficiency on the carcinogenic effect of estrogens and a protective role of iodine in maintaining normality of breast tissues. The risk for breast cancer is higher in women with fibrocystic disease of the breast (FDB), and iodine supplementation is effective against FDB.2-4
With this background of extensive information on the beneficial roles of iodine in seaweed against breast cancer, one would expect that a publication dealing with the protective role of iodine-rich seaweed against breast cancer would mention iodine as a possible factor in the list of bioactive substances. Here comes toxicologist Skibola, from UC-Berkeley, the birthplace of the Wolff-Chaikoff effect. In the August 2004 issue of BMC Complementary and Alternative Medicine,29 Skibola reported the effect of brown seaweed on menstrual cycle length and hormonal status in three pre-menopausal women with short menstrual cycles and prolonged menstrual flow. The seaweed was administered orally in a powder form compounded in gelatin capsules (seaweed supplements). In all three women, administration of seaweed resulted in a prolongation of the menstrual cycle, a decrease in menstrual flow, a marked drop in serum estradiol 17-B levels, and a marked increase in serum progesterone.29 In the list of potential substances in seaweed capable of eliciting such a beneficial effect on the ovaries, iodine was not mentioned once. In fact, the word „iodine“ was completely omitted in the publication. The amount of iodine in the seaweed used in her study was not reported. In a subsequent publication, Skibola, et al30 reproduced in female rats the results obtained with seaweed in women. Again they failed to mention iodine as a possible factor involved in the results obtained. These results reported by Skibola demonstrate a dramatic effect of seaweed on the ovaries of these women, normalizing ovarian function. The element iodine was reported by Russian scientists 40 years ago to elicit a similar effect in normalizing ovarian function in women with cystic ovaries.31
Two Russian scientists31 published in 1966 their results regarding the effect of oral administration of potassium iodide in daily amounts equivalent to 10-20 mg elemental iodine, on 200 patients with „dyshormonal hyperphasia of mammary glands.“ They postulated that this form of mastopathy was due to excess estrogens from ovarian follicular cysts which were caused iodine deficiency. The duration of iodine supplementation of their patients varied from six months to three years. Within three months, there was significant reduction of swelling, pain, diffuse induration, and nodularity of the breast. In five patients with ovarian follicular cysts, there was a regression of the cystic ovaries following five months to one year of iodine supplementation. Ghent, et al32 obtained similar results in FDB treated with iodine. We have observed similar responses to iodine supplementation at daily amounts of 50 mg iodine in the form of Lugol tablets in patients with polycystic ovary syndrome, resulting in the regularization of the menstrual cycle.2 Why Skibola chose to completely ignore iodine in her publications remains a mystery. Next to the thyoid gland, the ovaries contain the largest concentration of iodine.33 A sodium iodide symporter is present in the ovaries. This ovarian symporter is blocked by goitrogens. There is overwhelming evidence that iodine is the active ingredient in seaweed, eliciting the effects observed by Skibola on the ovaries of women.
Most Internet users do not go further than the information supplied on the Web. Rarely do they search further in the original studies. So, what is on the Net about Skibola’s studies? In an interview with Amy Norton,34 Skibola did mention iodine as a potentially toxic substance: „‚Adding seaweed to the diet is probably going to be beneficial,‘ Skibola said. However, she offered a word of caution about the kelp supplements sold at health food stores. Kelp contains high amounts of iodine, as well as low levels of heavy metals, and taking the seaweed in supplement form makes it easier to get too much of these potentially toxic substances. According to Skibola, kelp is not recommended for women who are pregnant or nursing, or for people with an overactive thyroid gland.“
Here, we have a perfect example of doublespeak. Skibola, who became an instant expert on iodine, advises against kelp supplements sold in health food stores because of the presence of the toxic substances iodine and heavy metals. Yet, she used in her studies, seaweed supplements made up of seaweed powder obtained from the same company that sells bulk seaweed powder to manufacturers who supply seaweed capsules to health food stores. Skibola is very concerned about toxic substances, such as iodine in seaweed from health food stores, but she never reported the levels of iodine present in the seaweed she used in her studies. Is that a double standard? Atlantic seaweed used extensively by the health food industry as a source of iodine, contains approximately 0.4% iodine (dry weight), that is 4 mg iodine/gm seaweed. In her studies of pre-menopausal women, she used a daily amount of 0.7-1.4 gm. Therefore, the daily intake of iodine in her study subjects would be 2.8 mg to 5.6 mg/day. That is the amount of iodine used by Ghent, et al32 to successfully treat FDB. Her recommendations to pregnant and nursing mothers to avoid seaweed, applies only to American women, not mainland Japanese women who regularly consume iodine-rich seaweed during pregnancy and lactation. According to Skibola, people with overactive thyroid gland should avoid seaweed because of the toxic element iodine. Remember the Wolff-Chaikoff effect? You can’t be too careful. Skibola may not be aware that prior to the Wolff-Chaikoff publication, US physicians used iodine in Lugol solution extensively, safely, and efficiently to treat overactive thyroid glands with as high as 90% success rate.3 Even Wolff and Chaikoff quoted the successful use of iodine to treat hyperthyroidism in the discussion of their publication.1
To wrap it up, proper amounts of iodine in the food supply should be considered one of a nation’s greatest assets. Removing iodine from the food supply is a form major mistake. Supplying daily intake of iodine for whole body sufficiency (100-400 times the RDA) gives protection2-4 against goitrogens and radioactive iodine/iodide fallout; improves immune functions, resulting in an adequate defense system against infection; decreases singlet oxygen formation which is the major cause of oxidative damage to DNA and macromolecules, resulting in an anticarcinogenic effect in every organ in the human body; results in a detoxifying effect by increasing urinary excretion of the toxic metals lead, mercury, cadmium, and aluminum, as well as the goitrogens fluoride and bromide; normalizes hormone receptor functions resulting in improved response to thyroid hormones both endogenous and exogenous; and results in better control of blood sugar in diabetic patients; stabilizes cardiac rhythm, obviating the need for the toxic sustained release form of iodine, amiodarone; and normalizes blood pressure without medication in hypertensive patients. Iodine deficiency is the major cause of cognitive impairment, worldwide.2Therefore, iodine sufficiency would result in optimal cognitive function, something of great importance to every nation.
The worst form of domestic bioterrorism is the dissemination of iodophobic misinformation in order to discourage the use of adequate amount of iodine for whole body sufficiency (orthoiodosupplementation).2-4 Today, the public relies heavily on the Internet for health information. Rarely do they search for the original publications. Whoever supplies health information on the Internet controls the health of the Internet user. Control of health information on the Internet by iodophobic bioterrorists is a real threat to a population who depends on this source of information to make health-related decisions. Such a population is vulnerable and most likely will end up adopting iodophobic decisions to their detriment. Once caught in the iodophobic Net, it becomes a vicious cycle, difficult to exit.
Iodophobic bioterrorism can be prevented through education of health care professionals and the public at large. Remember that the easiest and most effective way to destroy a nation is the removal of iodine from the food supply. Iodophobic bioterrorism is a real threat to our nation, and the enemies within our gates masquerade as guardians of our thyroid gland.
Guy E. Abraham, MD, is a former Professor of Obstetrics, Gynecology, and Endocrinology at the UCLA School of Medicine. Some 35 years ago, he pioneered the development of assays to measure minute quantities of steroid hormones in biological fluids. He has been honored as follows: General Diagnostic Award from the Canadian Association of Clinical Chemists, 1974; the Medaille d’Honneur from the University of Liege, Belgium, 1976; the Senior Investigator Award of Pharmacia, Sweden, 1980. The applications of Dr. Abraham’s techniques to a variety of female disorders have brought a notable improvement to the understanding and management of these disorders. Twenty-five years ago, Dr. Abraham developed nutritional programs for women with premenstrual tension syndrome and post-menopausal osteoporosis. They are now the most commonly used dietary programs by American obstetricians and gynecologists. Dr. Abraham’s current research interests include the development of assays for the measurement of iodide and the other halides in biological fluids and their applications to the implementation of orthoiodosupplementation in medical practice.
- Wolff J and Chaikoff IL. „Plasma inorganic iodide as a homeostatic regulator of thyroid function.“ J Biol Chem, 1948; 174:555-564.
- Abraham GE, Flechas JD, Hakala JC. „Othoiodosupplementation: Iodine sufficiency of the whole human body.“ The Original Internist, 2002; 9(4):30-41.
- Abraham GE. „The safe and effective implementation of orthoiodosupplementation in medical practice.“ The Original Internist, 2004; 11(1):17-36.
- Abraham GE. „The concept of orthoiodosupplementation and its clinical implications.“ The Original Internist, 2004; 11(2):29-38.
- Wartofsky L, Ransil BJ, and Ingbar SH. „Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis.“ J Clin Invest, 1970; 49:78-86.
- Gennaro AR. Remington: The Science and Practice of Pharmacy. 19th edition. Mace Publishing Co., 1995; 976, 1267.
- Wolff J. „Iodide goiter and the pharmacologic effects of excess iodide.“ Am J Med, 1969; 47:101-124.
- Koutras DA, et al. „Effect of small iodine supplements on thyroid function in normal individuals.“ J Clin Endocr, 1964; 24:857-862.
- Suzuki H, Higuchi T, Sawa K, et al. „Endemic coast goitre in Hokkaido, Japan.“ Acta Endocr, 1965; 50:161-176.
- Nagataki S, Shizume K, and Nakao K. „Thyroid function in chronic excess iodide ingestion: Comparison of thyroidal absolute iodine uptake and degradation of thyroxine in euthyroid Japanese subjects.“ J Clin Endo, 1967; 27:68-647.
- Konno N, Makita H, Yuri K, et al. „Association between dietary iodine intake and prevalence of subclinical hypothryoidism in the coastal regions of Japan.“ J Clin Endo Metab, 1994; 78:393-397.
- Stadel B. „Dietary iodine and risk of breast, endometrial, and ovarian cancer.“ The Lancet, 1976; 1:890-891.
- Eskin B, Bartuska D, Dunn M, et al. „Mammary gland dysplasia in iodine deficiency.“ JAMA, 1967; 200:115-119.
- Eskin B. „Iodine metabolism and breast cancer.“ Trans New York Acad Of Sciences, 1970; 32:911-947.
- Eskin B. „Iodine and mammary cancer.“ Adv Exp Med Biol, 1977; 91:293-304.
- Eskin B. Personal communication.
- Abraham GE, Flechas JD, and Hakala JC. „Optimum levels of iodine for greatest mental and physical health.“ The Original Internist, 2002; 9(3):5-20.
- Abraham GE. „Iodine supplementation markedly increases urinary excretion of fluoride and bromide.“ Townsend Letter, 2003; 238:108-109.
- Abraham GE. „Serum inorganic iodide levels following ingestion of a tablet form of Lugol solution: Evidence for an enterohepatic circulation of iodine.“ The Original Internist, 2004; 11(3):29-34.
- Abraham GE, Flechas JD, and Hakala JC. „Measurement of urinary iodide levels by ion-selective electrode: Improved sensitivity and specificity by chromatography on anion-exchange resin.“ The Original Internist, 2004; 11(4):19-32.
- Konno N, Yuri K, Miura K, et al. „Clinical evaluation of the iodide/creatinine ratio of casual urine samples as an index of daily iodide excretion in a population study.“ Endocrine Journal, 1993; 40(1):163-169.
- Nishiyama S, et al. „Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake.“ Thyroid, 2004; 14(12):1077-1083.
- Zimmermann MB, et al. „High thyroid volume in children with excess dietary iodine intakes.“ Am J Clin Nutr, 2005; 81:840-844.
- Wiseman R. „Breast cancer hypothesis: a single cause for the majority of cases.“ J Epid Comm Health, 2000; 54:851-858.
- Finley JW and Bogardus GM. „Breast cancer and thyroid disease.“ Quart Rev Surg Obstet Gynec, 1960; 17:139-147.
- Thomas BS, Bulbrook RD, Russell MJ, et al. „Thyroid function in early breast cancer.“ Europ J Cancer Clin Oncol, 1983; 19:1213-1219.
- Thomas BS, Bulbrook RD, and Goodman MJ. „Thyroid function and the incidence of breast cancer in Hawaiian, British, and Japanese women.“ Int J Cancer, 1986; 38:325-329.
- Smyth P. „Thyroid disease and breast cancer.“ J Endo Int, 1993; 16:396-401.
- Skibola C. „The effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: A case report.“ BMC Complementary and Alternative Medicine, 2004; 4:10:1-8.
- Skibola C, et al. „Brown kelp modulates endocrine hormones in female Sprague-Dawley rats and in human luteinized granulosa cells.“ J Nutr, 2005; 135:296-300.
- Vishnyakova VV and Murav’yeva NL. „On the treatment of dyshormonal hyperplasia of mammary glands.“ Vestn Akad Med Navk SSSR, 1966; 21:19-22.
- Ghent WR, Eskin BA, Low DA, et al. „Iodine replacement in fibrocystic disease of the breast.“ Can J Surg, 1993; 36:453-460.
- Slebodzinski AB. „Ovarion iodide uptake and triiodothyronine generation in follicular fluid. The enigma of the thyroid ovary interaction.“ Domest Anim Edocrinol, 2005; 29(1):97-103.
- Norton A. „Seaweed’s estrogen effects suggest cancer benefits.“ Reuters Health Information, February 10, 2005.
Lugolsche Lösung zur Therapie der Hyperthyreose
Studie 1970 an Hyperthyreoten Patienten bestätigt die vor Wolff-Charkofsky 1960 geübte alltagsmedizinische Praxis der (anorganischen) Jod-Therapie der Hyperthyreose: Wartofski 1970 (hier im FulltextPDF)
Details bitte aus obiger Abraham-Publikation
Karzinome Hormon-abhängiger Gewebe
Prostata, Brust und Ovarien enthalten – neben der Schilddrüse – die höchste Konzentration an JOD und den Na-Jodid-Symporter. In obiger Abraham-Publikation wird weidlich die krebsprophylaktische Wirkung regelmässiger ausreichender Jod-Versorgung (im Bereich der täglichen Aufnahme der Mainland-Japaner) auch studienmässig zitiert.
Die Japaner – 13.8mg Jod aus Algen pro Tag seit Jahrhunderten – haben bekanntermassen wenig Krebs. Sobald sie die Jodversorgung verringern (auf 1/100 der bei uns empfohlenen 150µg/d Jodid) explodiert deren Karzinom-Risiko.
neu: Magenkrebs, Schilddrüsenkrebs und Jodmangel
in den 90er Jahren wurde in Polen intensiviert Salz jodiert sowie Schwangeren und stillenden zusätzlich Jod verabreicht. Dies führte zum Eliminieren von Kretinismus (irreversibler Hirnschaden durch Jodmangel in der Kindheit) sowie zu einer bemerkenswerten Verminderung des Auftretens von Magenkrebs und Schilddrüsen-Krebs! polnische Studie 2017
andere Studie: ein Zusammenhang zwischen Kropf und Magenkrebs konnte festgestellt werden. Die Magenkrebs-Erkrankten hatten überzufällig häufig eine Schilddrüsen-Vergrösserung als Indiz einer mangelhaften Jod-Versorgung Studie 2013
letztlich: fast alle unsere Brustkrebspatientinnen nehmen Euthyrox !
das Beste ist aber: Wirksamkeit von IOD auf das Hirn
bitte lesen sie dazu meine Recherchen: Jod in der Schwangerschaft – v.a. die Hinweise aus der eigenen Praxis von Dr. Jorge Flecha
Was sollen wir Ärzte also tun?
uns informieren und Gehversuche mit 2 Tropfen täglich 5% Lugolscher Lösung (=12.6mg anorganisches Jod) als Therapeutikum (oder den Iodoral-Tabletten nach Abraham mit 12.5mg Jod) bei vielen unserer chronischer Patienten durchführen.
Man muss ja nicht gleich jedem Hyperthyreoten eine Jod-Hochdosis verpassen, wenn man „vorsichtig und guide-line-konform“ agiert.
Information: ist gar nicht so einfach, da das Abraham Buch vergriffen ist und sich die aktuelle Bücher-Situation v.a. an den Laien selber wendet mit der üblichen reichlichen Polemik und mässiger Wissenschaftlichkeit.
Die Reviews von Abraham sind in englisch und die meisten meiner ärztlichen Kollegen haben mit wissenschaftlichem Fachenglisch ihre Schwierigkeit. Falls ein geneigter Leser hier den Abraham Artikel übersetzen könnte, wäre ich sehr dankbar.
- Farrow, Lynne (Autor)
- 276 Seiten - 01.08.2015 (Veröffentlichungsdatum) - MobiWell (Herausgeber)